Marshall Wace North America L.P. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2021$1,069,000
+62.7%
21,341
+69.7%
0.01%
+25.0%
Q3 2019$657,000
-71.3%
12,573
-73.5%
0.00%
-71.4%
Q2 2019$2,290,000
+383.1%
47,415
+404.4%
0.01%
+600.0%
Q1 2019$474,000
+500.0%
9,400
+601.0%
0.00%
+100.0%
Q4 2018$79,000
-98.6%
1,341
-98.9%
0.00%
-96.7%
Q4 2017$5,451,000117,2930.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders